Important Best Practices that Support Research and Development in Drug Discovery by Improving Decision-Making Efficiency for the Pharmaceutical and Biotech Industries

Share Article

One Million Solutions in Health™ is honored to have Dr. Albert Giovenella from the University of Pennsylvania School of Medicine share important best practices that enhance decision-making efficiency in drug discovery for the biopharmaceutical industry

One Million Solutions in Health

One Million Solutions in Health

Accurate decision-making should be heavily based on scientific principles in the early part of the R&D process.

Important best practices that enhance decision-making efficiency in drug discovery for the biopharmaceutical industry -- are critical to the industry's future success. One Million Solutions in Health is honored have Albert J. Giovenella, Ph.D., Adjunct Assistant Professor of Medicine, University of Pennsylvania School of Medicine share his expertise on this webinar, “Supporting Research and Development in Drug Discovery".

In the past few years, a number of large pharmaceutical companies have sizeably reduced their R&D staffs while in the process of updating their business models. This has been an adjustment to greater licensing and outsourcing to find new compounds as the need has arisen to quickly fill their pipelines with promising assets. The latter has been an alternative to long and laborious efforts that are needed in pharmaceutical development.

There are some concepts to think about that might ease the pressure on this current situation, in which so many R&D employees have been turned out.

These concepts, which will be explained in this presentation are: (1) making an earlier “go-no go” decision in the discovery and development process, (2) putting more resources in the Phase III part of the process, since more certain assets and more work, including outcomes studies, would be characterizing this portion of development, (3) sticking to a steady in house to outsourcing ratio over a long period of time to stabilize important resources, and (4) training young entrepreneurs how to integrate scientific knowledge into key biotech business decision-making processes.

Accurate decision-making should be heavily based on scientific principles in the early part of the R&D process, and scientific-based decision making should be stressed in the education of young scientists.

Finally, keeping a large mechanism-based historic data set in each therapeutic area would allow the industry to construct a strong base to consult in starting difficult long-term scientific decisions for the future.

Review the webinar here: “Supporting Research and Development in Drug Discovery".

ABOUT One Million Solutions in Health:

As a not-for-profit, the goal of One Million Solutions in Health™ is to shape health care by sharing solutions and, importantly, to accelerate the discovery, development and delivery ... of innovative cures, treatments and preventative measures for patients around the world. By facilitating efforts to ensure organizations can Connect, Learn + Share, Innovate and Collaborate, our vision is to improve health care delivery, accelerate life sciences research and share patient and consumer-focused ideas and solutions.

By engaging scientists, entrepreneurs, investors, innovators, industry experts, health care professionals, and patients across various disciplines, and from around the world, we can utilize the power of the internet to disrupt things in a positive and transformative way to accelerate the movement of new solutions and scientific discoveries from the scientist to the patient.

The Technology Evaluation Consortium (TEC) brings together life sciences and/or health care companies and technology providers, and other relevant partners (e.g., government and Universities) to evaluate and validate technologies or services in a collaborative environment. The model empowers technology providers and industry end users to collectively assess a number of technologies in a cost-effective manner, producing a depth and breadth of results that no company can achieve alone.

We are on our way towards accelerating high-potential innovations, catalyzing investment and increasing awareness of, and support for, important ideas to improve health and save lives. We are thrilled to have you be a part of this transformative journey!

If you have a technology, scientific discovery or medical solution you would like us to help SHARE WITH THE WORLD, contact us.

For more information: http://www.onemillionsolutionsinhealth.org

CONTACT:

One Million Solutions in Health™
Dawn Van Dam
Executive Director & CEO
Email: dawn.vandam(at)onemillionsolutionsinhealth(dot)org
Phone: 416-402-8274
Twitter: @DawnVanDam

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dawn Van Dam
@DawnVanDam
since: 03/2011
Follow >
One Million Solutions in Health
Like >
One Million Solutions in Health

Follow us on
Visit website